PainReform Ltd.

NasdaqCM PRFX

PainReform Ltd. Dividend Yield on December 30, 2024: 0.00%

PainReform Ltd. Dividend Yield is 0.00% on December 30, 2024, a 0.00% change year over year. Dividend yield measures the dividend per share relative to stock's price value; higher yield suggests higher dividend return.

PainReform Ltd. 52-week high Dividend Yield is 0.00% on December 30, 2024, which is 0.00% below the current Dividend Yield.
PainReform Ltd. 52-week low Dividend Yield is 0.00% on December 30, 2024, which is 0.00% below the current Dividend Yield.
PainReform Ltd. average Dividend Yield for the last 52 weeks is 0.00%.

Key data

Date	Dividend Yield	Free Cash Flow Yield	Earnings Yield	Enterprise Value (EV)

NasdaqCM: PRFX

PainReform Ltd.

CEO	Dr. Ehud Geller Ph.D.
IPO Date	Sept. 1, 2020
Location	Israel
Headquarters	65 Yigal Alon Street
Employees	7
Sector	Health Care
Industries Pharmaceuticals Clinical Trials

Description

PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. It engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company is currently conducting two Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair. PainReform Ltd. was incorporated in 2007 and is based in Tel Aviv, Israel.

Key trends

Past 5 years